Filter
986
Filtered Results: 986
Text search:
pharmaceutical
procurement
Featured
Recommendations
106
New Publications
307
Language
Document type
No document type
508
Studies & Reports
181
Guidelines
152
Strategic & Response Plan
59
Manuals
44
Fact sheets
18
Training Material
10
Situation Updates
9
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Ethiopia
55
Kenya
50
Global
34
India
33
Uganda
28
South Africa
26
Sierra Leone
25
Nigeria
23
Liberia
23
Ghana
20
Malawi
19
Tanzania
19
Nepal
17
Rwanda
17
Western and Central Europe
16
Zambia
16
Bangladesh
14
Ukraine
13
Namibia
13
Zimbabwe
12
Philippines
12
Africa
12
Lesotho
11
Eastern Europe
9
Syria
8
Cambodia
8
Senegal
7
Latin America and the Carribbean
7
Congo, Democratic Republic of
7
Myanmar / Burma
7
Botswana
6
Indonesia
6
Eswatini/ Swaziland
6
Benin
5
Cameroon
5
Burkina Faso
5
Asia
5
South–East Asia Region
5
Haiti
4
West and Central Africa
4
East and Southern Africa
4
Guinea
3
Mozambique
3
North America
3
Papua New Guinea
3
Sudan
3
Thailand
2
Albania
2
Jordan
2
Middle East and North Africa
2
Western Pacific Region
2
Lebanon
2
Yemen
2
South Sudan
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Fiji
1
Laos
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Gabon
1
Maldives
1
Southern Africa
1
Brazil
1
Moldova
1
Russia
1
Central African Republic
1
Mali
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
492
Clinical Guidelines
58
Key Resources
46
Public Health
38
Pharmacy & Technologies
23
Women & Child Health
22
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
Pharmacy
109
AMR
95
COVID-19
65
HIV
58
TB
52
Rapid Response
26
NTDs
24
Health Financing Toolbox
22
Planetary Health
20
Conflict
16
NCDs
15
Global Health Education
13
Mental Health
11
Ebola & Marburg
11
Caregiver
9
Natural Hazards
4
Polio
3
Refugee
2
Disability
2
Cholera
2
Specific Hazards
1
Zika
1
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...
Available in English, French and Spanish
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
WHO Vaccine Management Handbook
Fourth edition
SITUATION ANALYSIS AND RECOMMENDATIONS
The health sector In Ukraine is beginning to change in recent years. The sector, based on a system of health care (Semashko) originating from the Soviet Union, had been stagnant for many years. Remarkably little had changed since Independence and the health care system is as of today still character...
Background paper 7
The Independent Panel for Pandemic Preparedness and Response
May 2021
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptio...
